Immune‐Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration‐Approved Indications for Immunotherapy

INTRODUCTION: Immune‐related adverse event (IRAE) onset may represent a clinical biomarker for anti‐programmed cell death protein 1 (PD‐1) antibody response based on emerging evidence from patients with various advanced malignancies. This phenomenon has not been previously reported in a multidisease...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Das, Satya, Ciombor, Kristen K., Haraldsdottir, Sigurdis, Pumpalova, Yoanna, Sahin, Ibrahim H., Pineda, G., Shyr, Yu, Lin, E.P., Hsu, Chih‐Yuan, Chu, Shih‐Kai, Goff, Laura W., Cardin, Dana B., Bilen, Mehmet A., Fisher, George A., Wu, Christina, Berlin, Jordan
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7418359/
https://ncbi.nlm.nih.gov/pubmed/31943525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0637
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados